3,062 research outputs found

    Small bowel motility quantitation using MRI and its relationship to gastrointestinal symptoms

    Get PDF
    The small bowel is difficult to analyse due to its deep anatomical location and the large variation seen in individuals, in regard to both anatomy and function including motility. Dynamic MRI allows small bowel motility to be captured and visually assessed by radiologists, but there is often large inter-observer variation and a lack of complicated motility patterns being investigated. This thesis aims to explore the link between abnormal motility and gastrointestinal (GI) symptoms in Crohn’s disease (CD) and irritable bowel syndrome (IBS) using MRI. Firstly, a scan duration of 15 seconds and a temporal resolution of 1 image per second were shown to be sufficient for robust small bowel MRI motility measurements. Next, a validation study confirmed an association between aberrant motility and CD patient symptoms, particularly diarrhoeal stools (rho = -0.29). The strongest association was in patients with higher symptom severity (rho = -0.633). Building on this work, more complex motility metrics were developed and compared to subjective radiological scoring. Spatial and temporal variation were found to be associated with CD patient symptoms and were also particularly difficult to visually assess. The motility metrics were applied in clinical IBS data to explore differences in IBS subgroups. Significantly reduced temporal variation of motility (P < 0.001) and area of motile bowel (P < 0.001) was found in IBS-C (constipation-predominant) compared to IBS-M (mixed constipation and diarrhoea). Finally, texture analysis (TA) terminal ileum (TI) to colon ratios were found to be higher for TA contrast (P = 0.005) and lower for TA energy (P = 0.03) in IBS-C compared to healthy controls (HCs). Ascending colon diameter was shown to be significantly larger in IBS-C than HCs (P = 0.005)

    A review of artificial intelligence in prostate cancer detection on imaging

    Get PDF
    A multitude of studies have explored the role of artificial intelligence (AI) in providing diagnostic support to radiologists, pathologists, and urologists in prostate cancer detection, risk-stratification, and management. This review provides a comprehensive overview of relevant literature regarding the use of AI models in (1) detecting prostate cancer on radiology images (magnetic resonance and ultrasound imaging), (2) detecting prostate cancer on histopathology images of prostate biopsy tissue, and (3) assisting in supporting tasks for prostate cancer detection (prostate gland segmentation, MRI-histopathology registration, MRI-ultrasound registration). We discuss both the potential of these AI models to assist in the clinical workflow of prostate cancer diagnosis, as well as the current limitations including variability in training data sets, algorithms, and evaluation criteria. We also discuss ongoing challenges and what is needed to bridge the gap between academic research on AI for prostate cancer and commercial solutions that improve routine clinical care

    Signs of progression:MR image analysis for the management of low-grade glioma

    Get PDF
    Every year approximately one thousand people in the Netherlands are diagnosedwith diffuse glioma, a type of infiltrative brain tumor that originates from theglial cells. There is no curative treatment available for adults diagnosed witha diffuse glioma, although surgical resection, radiotherapy and chemotherapyare used to improve prognosis and decrease symptoms. Low-grade glioma canremain stable for long periods of time before, inevitably, malignant progressionoccurs. The radiological assessment of glioma through magnetic resonanceimaging (MRI) plays an important role in the management of glioma. Inthis thesis I explore the role of quantitative measurements, emerging imagingmarkers and predictive modelling in the management of glioma. These methodscan aid the radiologist to predict the timing, location and severity of tumorprogression, to ultimately improve the quality of life for glioma patients.<br/
    corecore